- Home
- MNSB vs CDXS Comparison
MNSB vs CDXS Comparison
Compare MNSB & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNSB | CDXS |
|---|---|---|
| Founded | 2003 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Major Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.1M | 154.4M |
| IPO Year | 2017 | 2008 |
Fundamental Metrics
Financial Performance| Metric | MNSB | CDXS |
|---|---|---|
| Price | $22.10 | $1.08 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $6.14 |
| AVG Volume (30 Days) | 32.5K | ★ 846.3K |
| Earning Date | 10-26-2026 | 11-12-2026 |
| Dividend Yield | ★ 1.85% | N/A |
| EPS Growth | ★ 210.00 | 43.82 |
| EPS | ★ 1.05 | N/A |
| Revenue | $135,615,000.00 | ★ $138,590,000.00 |
| Revenue This Year | N/A | $4.97 |
| Revenue Next Year | N/A | $18.69 |
| P/E Ratio | $20.91 | ★ N/A |
| Revenue Growth | N/A | ★ 32.30 |
| 52 Week Low | $17.97 | $0.96 |
| 52 Week High | $25.87 | $2.98 |
Technical Indicators
Market Signals| Indicator | MNSB | CDXS |
|---|---|---|
| Relative Strength Index (RSI) | 39.28 | 36.20 |
| Support Level | $21.32 | $0.96 |
| Resistance Level | $25.32 | $1.24 |
| Average True Range (ATR) | 0.80 | 0.08 |
| MACD | -0.06 | -0.02 |
| Stochastic Oscillator | 28.59 | 23.53 |
Price Performance
Historical ComparisonAbout MNSB MainStreet Bancshares Inc.
MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.
About CDXS Codexis Inc.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.